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Abstract Vitamin B12 (cobalamin) is the most complex B-type vitamin and is synthetized
exclusively in a limited number of prokaryotes. Its biologically active variants contain rare
organometallic bonds, which are used by enzymes in a variety of central metabolic pathways such
as L-methionine synthesis and ribonucleotide reduction. Although its biosynthesis and role as co-
factor are well understood, knowledge about uptake of cobalamin by prokaryotic auxotrophs is
scarce. Here, we characterize a cobalamin-specific ECF-type ABC transporter from Lactobacillus
delbrueckii, ECF-CbrT, and demonstrate that it mediates the specific, ATP-dependent uptake of
cobalamin. We solved the crystal structure of ECF-CbrT in an apo conformation to 3.4 A˚ resolution.
Comparison with the ECF transporter for folate (ECF-FolT2) from the same organism, reveals how
the identical ECF module adjusts to interact with the different substrate binding proteins FolT2 and
CbrT. ECF-CbrT is unrelated to the well-characterized B12 transporter BtuCDF, but their
biochemical features indicate functional convergence.
DOI: https://doi.org/10.7554/eLife.35828.001
Introduction
Vitamin B12 or cobalamin (Cbl) is regarded as the largest and most complex biological ‘small mole-
cule’. The molecule consists of a corrin ring chelating a cobalt ion using four equatorial coordinating
nitrogen atoms (Figure 1, Figure 1—figure supplement 1). At the a-axial position, the cobalt ion is
coordinated by the 5,6-dimethylbenzimidazole (DMBI) base that is linked covalently to the corrin
ring. Located at the b-axial position is the sixth coordinating moiety (Gruber et al., 2011;
Roth et al., 1996). This ligand can vary among cobalamin derivatives and forms a rare organometal-
lic, covalent bond, which offers unique catalytic properties to enzymes that use Cbl as a co-factor.
The two most common biological active variants have a methyl or 5’-deoxyadenosyl group at this
position, resulting in methyl- and adenosyl-cobalamin (Met-Cbl and Ado-Cbl, respectively). In the
industrially produced variant, a cyano-group (CN-Cbl) binds at the b-axial position, and a hydroxy
group (OH-Cbl) is present in the degradation product (Gruber et al., 2011).
Enzymes that use Cbl as their co-factor catalyze mostly methyl group transfer reactions, or a vari-
ety of different radical-mediated reactions (Giedyk et al., 2015; Gruber et al., 2011). The most
prominent example for methyl group transfer is MetH, the Cbl-dependent L-methionine synthase,
which uses Met-Cbl to transfer a methyl group onto L-homocysteine to produce L-methionine. The
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methyl group on Cbl is subsequently restored from methyl-folate (Banerjee and Matthews, 1990;
Gruber et al., 2011).
The ability to synthesize Cbl de novo is restricted to prokaryotic species in only ~20 genera. Two
routes for de novo synthesis have been established (aerobic or anaerobic), each requiring approxi-
mately 30 different enzymes, which makes de novo synthesis a very energy consuming process, and
could explain why roughly two thirds of prokaryotes that require Cbl cannot synthesize the molecule,
and hence depend on uptake (Gruber et al., 2011; Roth et al., 1996). For some microbial commu-
nities, for instance in the Ross Sea, it has been shown that Cbl production is the limiting factor for
biomass production, which generates a demand for Cbl uptake systems among Cbl auxotrophs
(Bertrand et al., 2011).
In contrast to the well-characterized chemical properties of Cbl, as well as its biosynthesis and
role in many enzymatic reactions, the uptake of the vitamin by bacteria is poorly understood. The
only characterized Cbl uptake system is the Escherichia coli BtuCDF ATP binding cassette (ABC)
transporter, which was first described in 1980 (DeVeaux and Kadner, 1985). Substantial under-
standing of the system has been obtained through a combination of biochemical and structural stud-
ies (Borths et al., 2002; Goudsmits et al., 2017; Korkhov et al., 2012; Korkhov et al., 2014;
Locher et al., 2002). The importer uses the periplasmic substrate-binding protein BtuF to capture
Cbl or its precursor cobinamide (Cbi) with high affinity (Kd values of ~10 nM and ~40 nM, respec-
tively) (Cadieux et al., 2002; Mireku et al., 2017). Transport is powered by hydrolysis of ATP by the
two BtuD subunits located on the cytoplasmic side of the membrane (Borths et al., 2005). The sub-
strate passes through the membrane at the interface between two copies of the transmembrane
protein, BtuC (Korkhov et al., 2012; Korkhov et al., 2014). BtuCDF homologs are found widely in
prokaryotes, but they are absent from a subset of bacteria that require uptake of vitamin B12
(Rodionov et al., 2009).
An in silico study by Rodionov et al. (2009) predicted that the energy coupling factor (ECF-) type
ABC transporter ECF-CbrT might be a Cbl transporter (Rodionov et al., 2009). ECF-transporters
are multi-subunit membrane complexes that consist of two ATPases, similar to the ATPases of ABC
transporters, and two membrane embedded proteins, not related to any other protein family
Figure 1. Structures of cobalamin and cobinamide. (a) Cobalamin structure, represented in the base-on
conformation with the 5’,6’-dimethyl-benzimidazole ribonucleotide moiety (a-ligand) coordinating the central
cobalt ion. The variable b-ligands are denoted as R in the lower left corner. (b) Structure of cobinamide, which
lacks the DMBI moiety and has two cyano groups coordinating the cobalt ion from each side of the corrin ring.
DOI: https://doi.org/10.7554/eLife.35828.002
The following figure supplement is available for figure 1:
Figure supplement 1. 3D structures of cobalamin and cobinamide.
DOI: https://doi.org/10.7554/eLife.35828.003
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(Slotboom, 2014). The two ATPases and one of the transmembrane proteins, EcfT, form the ‘ener-
gizing unit’ or ’ ECF-module’. The other membrane protein, termed S-component, acts as the sub-
strate-binding protein and dynamically associates with the ECF-module to allow for substrate
translocation. In so-called group II ECF transporters, multiple S-components specific for different
substrates interact with the same ECF module (Berntsson et al., 2012; Henderson et al., 1979;
Karpowich et al., 2015; Majsnerowska et al., 2015; ter Beek et al., 2011). For instance, in Lacto-
bacillus delbrueckii eight different S-components are predicted to share a single ECF module, one
of which, CbrT, was predicted to be specific for Cbl (Rodionov et al., 2009; Swier et al., 2016).
In this work, we biochemically and structurally characterize the ECF-CbrT complex from L. del-
brueckii. We demonstrate that ECF-CbrT is a Cbl transporter that catalyses ATP-dependent uptake
of Cbl and its precursor Cbi. We show that the S-component CbrT mediates high affinity substrate-
specificity for Cbl and Cbi, and we report the crystal structure of ECF-CbrT from L. delbrueckii at 3.4
A˚ resolution in its apo inward-facing state. Although ECF-CbrT is structurally and mechanistically
unrelated to BtuCDF, the kinetic parameters of the two transporters are very similar, suggestive of
functional convergence.
Results
Expression of ECF-CbrT complements an Escherichia coli strain lacking
its endogenous vitamin B12 transporter
To demonstrate that ECF-CbrT is a vitamin B12 transporter, we constructed an Escherichia coli
knock-out strain with three genomic deletions: DbtuF, DmetE, and DbtuC::KmR (E. coli DFEC)
(Baba et al., 2006; Datsenko and Wanner, 2000; Thomason et al., 2007). A similar strain was pre-
viously used by Cadieux et al., 2002 to identify the substrate binding protein BtuF. The knock-out
strain lacks the L-methionine synthase MetE (Davis and Mingioli, 1950). E. coli possesses two
L-methionine synthases, MetE and MetH. MetH uses Cbl as cofactor, whereas MetE is not depen-
dent on the vitamin (Banerjee et al., 1989; Davis and Mingioli, 1950). Thus, deletion of metE
makes E. coli dependent on Cbl for the synthesis of L-methionine. Because btuF and btuC are also
deleted in E. coli DFEC, endogenous Cbl-uptake mediated by BtuCDF is abolished (Cadieux et al.,
2002), and (heterologous) expression of an active Cbl transporter is required to synthesize
methionine.
We studied the growth of the deletion strain transformed with an expression plasmid for either
BtuCDF (positive control), or an empty plasmid (negative control), or CbrT with or without the ECF
module. We grew cells in 96-well plates using minimal medium supplemented with L-methionine or
Cbl and monitored the optical density at 600 nm (OD600). In the presence of L-methionine, all strains
grew readily, with a lag phase of 300–450 min (Figure 2a–d) (Zwietering et al., 1990). The strains
expressing BtuCDF or ECF-CbrT showed similar growth characteristics (lag time of 380 min and 470
min, respectively) in medium containing Cbl instead of L-methionine (Figure 2a and c, respectively),
whereas the deletion strain expressing solitary CbrT (without its cognate ECF-module) did not show
substantial growth in the absence of L-methionine when supplemented with Cbl (Figure 2d). The
results demonstrate that the full ECF-CbrT complex constitutes a new Cbl transporter. ECF-CbrT
also supported growth of E. coli DFEC in the presence of Cbi instead of Cbl, albeit with a longer lag-
time (730 min) (Figure 2c), indicating that Cbi is a transported substrate of ECF-CbrT. We hypothe-
size that the longer lag time is due to the extra time required to express the necessary enzymes for
Cbl synthesis from Cbi (Lawrence and Roth, 1995). Our in vitro work shows that ECF- CbrT indeed
supports efficient Cbl and Cbi transport (see below).
ECF-CbrT catalyzes ATP-dependent transport of cobalamin and
cobinamide
We purified ECF-CbrT, reconstituted the complex in liposomes and assayed for the uptake of radio-
labeled Cbl (57Co-cyanocobalamin). Uptake of radiolabeled Cbl into proteoliposomes was observed
only when the proteoliposomes were loaded with Mg-ATP and not when Mg-ADP was incorporated
(Figure 3a). While this experiment shows that transport is strictly ATP-dependent, similar to what
was found for other ECF transporters (Swier et al., 2016; ter Beek et al., 2011), the ratio between
ATP molecules hydrolyzed and Cbl molecules transported cannot be derived from this data. To
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obtain this ratio, simultaneous measurements of Cbl uptake and ATP hydrolysis rates are needed,
which is technically difficult. Additionally, the related ECF transporter for folate displays a large
extent of futile ATP hydrolysis (not coupled to transport [Swier et al., 2016]), which further compli-
cates the determination of the coupling ratio. Nonetheless, the EcfA and EcfA’ subunits contain all
the motifs to form functional ATPases, and therefore we speculate that transport of Cbl is coupled
to the hydrolysis of two ATP molecules. Using an Mg-ATP concentration of 5 mM, the apparent KM
for Cbl uptake was 2.1 ± 0.4 nM and the Vmax = 0.06 ± 0.01 nmol  mg
 1
 s 1 (Figure 3—figure
supplement 1). To test the substrate specificity of the new vitamin B12 transporter, we conducted
uptake experiments with a variety of competing compounds that are structurally similar to Cbl
(Figure 3b). Addition of a 250-fold excess of unlabeled CN-Cbl inhibited the uptake of the radiola-
beled substrate almost completely. Met-Cbl and OH-Cbl inhibited uptake to a similar extent as CN-
Cbl, whereas Ado-Cbl was less effective (inhibition to ~25%). Addition of a 250-fold excess of Cbi
also decreased the uptake of radiolabeled Cbl to ~25% (Figure 3b). To test whether Cbi is a trans-
ported substrate (that competitively inhibits transport of Cbl) or a non-transported compound that
can only bind to the transporter, we directly measured uptake of Cbi (Figure 3a). Radiolabeled Cbi
is not commercially available and, therefore, we synthesized the compound by treating 57Co-cyano-
cobalamin with perchloric acid (Schneider and Stroinski, 1987). The complete conversion of Cbl into
Cbi was confirmed by mass spectrometry. Cbi was transported into liposomes containing ECF-CbrT,
and transport required lumenal Mg-ATP, confirming that Cbi is a transported substrate (Figure 3a).
Finally, we tested whether hemin inhibits Cbl transport (Figure 3b). Hemin and Cbl are structurally
related and share the same precursor uroporphyrinogen-III (Roth et al., 1996), but unlike Cbl, hemin
consists of a flat porphyrin ring with a chelated iron ion, and has a chloride ion as one of the axial
Figure 2. ECF-CbrT supports cobalamin-dependent growth of an E.coli deletion strain. (a) The triple knock out
strain E. coli DFEC expressing the BtuCDF ABC-transporter (positive control) grows in the presence of 50 mg/ml
L-methionine or 1 nM CN-Cbl with lag-times of 300 min or 380 min, respectively, (b) E. coli DFEC carrying only the
empty expression vector (negative control) grows only in the presence of 50 mg/ml L-methionine but not with 1 nM
CN-Cbl. The lag-times of the negative controls are 450 min or >1000 min, respectively. (c) E. coli DFEC expressing
the entire ECF-CbrT transporter supports growth in the presence of either 1 nM Cbl or 1 nM Cbi with a lag-time of
470 min or 730 min, respectively. The lag-time in the presence of 50 mg/ml L-methionine is 410 min. (d) Expression
of the solitary S-component CbrT without its cognate ECF-module is not able to support growth of E. coli DFEC in
the presence of 1 nM CN-Cbl.
DOI: https://doi.org/10.7554/eLife.35828.004
Santos et al. eLife 2018;7:e35828. DOI: https://doi.org/10.7554/eLife.35828 4 of 16
Research article Biochemistry and Chemical Biology Structural Biology and Molecular Biophysics
ligands. Hemin did not compete with Cbl-uptake (Figure 3b), showing that, although promiscuous
among Cbl variants and Cbl-precursors, ECF-CbrT is a dedicated vitamin B12 transporter.
We aimed to obtain further biochemical information on the solitary S-component CbrT. We could
purify CbrT only in the substrate-bound state (Figure 4a). The protein without substrate was unsta-
ble in detergent solution and prone to aggregation. Apparently, substrate binding had a stabilizing
effect on CbrT, an observation that has been made more often for membrane proteins
(Berntsson et al., 2012; ter Beek et al., 2011).
From the spectral properties of Cbl that was co-purified with CbrT, we conclude that CbrT binds
Cbl in a ~ 1:1 ratio in detergent solution (Figure 4a), which reflects the common substrate to protein
stoichiometry for S-components (Berntsson et al., 2012; Erkens et al., 2011; Swier et al., 2016).
Because we could not obtain purified apo CbrT, we studied the substrate-binding affinity using E.
coli crude membrane vesicles (CMVs) containing overexpressed apo CbrT. Isothermal titration calo-
rimetry (ITC) revealed binding of both CN-Cbl and Cbi with dissociation constants of 9.2 ± 4.5 nM
and 36 ± 15 nM, respectively (Figure 4b,c and e). As a negative control, CMVs without CbrT were
used to exclude unspecific binding of CN-Cbl or Cbi (Figure 4d). Cbl analogues, OH-Cbl and Met-
Cbl, were also probed with ITC and found to bind to CbrT with the similar binding affinities as CN-
Cbl (Kd values of 9.6 ± 6.9 nM or 4.5 ± 0.3 nM, respectively, Figure 4—figure supplement 1), sup-
porting the notion that CbrT is promiscuous towards the b-axial ligand of Cbl and corroborating the
findings of the competition assay.
Although the use of crude membrane vesicles precluded the determination of the number of
binding sites (the concentration of CbrT in the membrane vesicles is unknown), the thermodynamic
values (Kd, DH and DS) derived from the ITC measurements do not depend on this number. Assum-
ing that CbrT has a single substrate binding site (consistent with the spectral properties, Figure 4a),
the expression level of CbrT in the membranes could be calculated and we found that CbrT
accounted for ~0.9% (w/w) of the protein content in the membrane.
Figure 3. 57Co-cyanocobalamin (cyano-Cbl) and 57Co-cobinamide (Cbi) transport by purified and reconstituted
ECF-CbrT. (a) ATP-dependent uptake of radiolabeled CN-Cbl and Cbi by ECF-CbrT in proteoliposomes.
Proteoliposomes were loaded with either 5 mM Mg-ATP (circles for CN-Cbl, triangles for Cbi) or 5 mM Mg-ADP
(CN-Cbl, squares). (b) Competition assay using Cbl-analogues. The initial uptake rate at 1 nM 57Co-
cyanocobalamin (CN-Cbl) was measured. Competing compounds (adenosyl-cobalamin (Ado-Cbl); methyl-
cobalamin (CH3-Cbl); hydroxyl-cobalamin (OH-Cbl); cobinamide or hemin) were added at a concentration of 250
nM. The uptake was normalized to a condition without competitor (10 pmol*mg 1*min 1). Since hemin is not
readily soluble in an aqueous solution, we added 1% (v/v) DMSO during the assay, which did not affect the
transporter activity. All competition experiments were performed in triplicate and the error bars indicate the
standard deviation (s.d.).
DOI: https://doi.org/10.7554/eLife.35828.005
The following figure supplement is available for figure 3:
Figure supplement 1. Kinetics of cobalamin uptake by ECF-CbrT.
DOI: https://doi.org/10.7554/eLife.35828.006
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Structure of the vitamin B12-specific ECF transporter in its apo and
post substrate-release state
We crystallized the ECF-CbrT complex in detergent (n-Dodecyl-b-D-maltopyranoside, DDM) solution
and solved a crystal structure to 3.4 A˚ resolution using molecular replacement with the structure of
the folate transporter, ECF-FolT2, from L. delbrueckii as a search model (Figure 5a) (Swier et al.,
2016). Statistics of data collection and structure refinement are summarized in Supplementary file
1. There are two copies of ECF-CbrT in the asymmetric unit, corresponding to molecules A and B,
each of them comprising CbrT, EcfT, EcfA and EcfA’.
The identical ECF modules of the ECF-FolT2 and ECF-CbrT complexes have very similar overall
structures, with a few notable conformational differences (Figure 5b). In both complexes, the two
Figure 4. Cobalamin and cobinamide binding to CbrT. (a) Co-purification of CN-cobalamin with CbrT. The elution
peak of the size exclusion column at a volume of 14 ml contains purified CbrT. The protein absorbs at 280 nm and
CN-Cbl at 361 nm, showing that CbrT is eluted bound to CN-Cbl. (b) and (c) ITC measurements of Cbl and Cbi
binding to CbrT. The determined Kd values for Cbl and Cbi were averaged from triplicate measurements and the
error is s.d. (d) ITC measurement showing the absence of Cbl-binding to the full complex, ECF-CbrT. Fitting of
single binding site models to the data is shown in panel (e).
DOI: https://doi.org/10.7554/eLife.35828.007
The following figure supplement is available for figure 4:
Figure supplement 1. Binding of Cbl-analogs to CbrT.
DOI: https://doi.org/10.7554/eLife.35828.008
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Figure 5. Comparison of the structures of ECF-CbrT and ECF-FolT from L.delbrueckii. (a) Cartoon representation of ECF–CbrT from the perspective of
the plane of the membrane. Cytoplasmic ATPases, EcfA and EcfA’, are colored in red, EcfT in cyan and CbrT in yellow. (b) Structural differences
between the membrane domains of EcfT. The structures of ECF-CbrT (cyan) and ECF-FolT2 (green) from L. delbrueckii were superimposed by structural
alignment of the ATPase units. Pro71 of EcfT is represented in sticks. (c) and (d) Surface representation of CbrT (c, yellow) and FolT2 (d, orange)
Figure 5 continued on next page
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nucleotide-binding domains (NBDs; EcfA and EcfA’) are in a nucleotide-free state, adopting an open
conformation with two incomplete ATP-binding sites. With the NBDs of ECF-FolT2 and ECF-CbrT
aligned structurally (rmsd 1.8 A˚), the coupling helices of EcfT, which transmit the conformational
changes of the NBDs upon ATP-hydrolysis to the membrane domains, also superimpose well
between the two complexes (rmsd 1.5 A˚). However, the transmembrane-helices of EcfT adopt differ-
ent conformations (rmsd 4.4 A˚). They are offset like rigid bodies, hinging approximately around
Pro71 (Figure 5b). Structural flexibility of the membrane domain has been observed before
(Swier et al., 2016; Zhang et al., 2014) and is likely necessary to accommodate different S-compo-
nents, and may facilitate toppling of the S-components during the catalytic cycle (Swier et al.,
2016).
The S-components CbrT and FolT2, which interact with the same ECF module in L. delbrueckii,
do not share significant sequence similarity (16% identical residues). Accordingly, the structures
show pronounced differences (rmsd 3.1 A˚), although the overall folds are the same. Particularly, dif-
ferences in loop 3 and loop 5 cause alterations of the protein surfaces that interact with the mem-
brane domain of EcfT (Figure 5c,d). Therefore, tight association of the different S-components with
the same ECF module requires the conformational adaptations in the membrane domain of the
interacting EcfT subunits (Figure 5c,d).
CbrT is in a ‘toppled’ orientation in the ECF-CbrT complex with TMs 1, 2, 3 and 4 oriented almost
parallel to the membrane plane. Although OH-Cbl was added in excess to the crystallization condi-
tion, the substrate was not bound. The apo-state of the toppled S-component was observed before
in other ECF-type transporters and likely represents the inward-facing state after substrate release
(Swier et al., 2016; Wang et al., 2013; Xu et al., 2013; Zhang et al., 2014). The absence of sub-
strate is in agreement with the proposed transport model, in that the inward oriented apo protein is
a low affinity state (Swier et al., 2016). It has been hypothesized that this state precedes ATP hydro-
lysis, which leads to release of the S-component from the ECF module and reorientation of the
S-component in the membrane, which brings the substrate binding site back to the extracellular side
(Swier et al., 2016).
We hypothesize that the binding site for Cbl is located in a large cavity observed in the CbrT
structure. The location of the cavity matches the position of the substrate-binding sites in structurally
characterized S-components in the substrate-bound state (Berntsson et al., 2012; Erkens et al.,
2011; Swier et al., 2016). In contrast to ECF-FolT2 (Swier et al., 2016), and structurally character-
ized ECF complexes from other organisms (Wang et al., 2013; Xu et al., 2013; Zhang et al., 2014),
the binding cavity in ECF-CbrT is largely occluded, and not accessible from the cytosol (Figure 5e,f).
The occlusion is caused mainly by the position of loop 3, which obstructs access to the cavity in
CbrT. We speculate that occlusion of the empty binding site after cytoplasmic release of the sub-
strate may be required for the subsequent reorientation of the S-component, upon release from the
ECF module.
Discussion
Comparative genomics studies have identified a wide range of ECF transporter families along with
their putative substrate specificities mediated by their S-components (Rodionov et al., 2009). Based
on its genetic organization and the lack of a BtuCDF transporter homolog in the Lactobacillales
genomes, CbrT was predicted to be a vitamin B12-specific S-component (Rodionov et al., 2009). In
L. delbrueckii, which was shown to be auxotrophic for vitamin B12 (Kusaka and Kitahara, 1962),
CbrT occurs within the nrdJ–cbrS–cbrT–pduO gene cluster. This genetic organization strongly
implies an involvement of the substrate-binding protein CbrT in Cbl uptake: First, nrdJ is annotated
as an adenosylcobalamin-dependent ribonucleotide reductase requiring the vitamin as a co-factor.
Figure 5 continued
interacting with EcfT (cartoon representation coloured in grey) with loop 3 of the S-components colored in blue. A dashed line highlights the
movement of transmembrane helix 3 of EcfT. (e) and (f) Loop 3 obstructs access to the substrate binding cavity in CbrT but not in FolT2. (e) Slice-
through of CbrT in surface representation, viewed from the plane of the membrane. Loop 3 is colored in blue. The ECF module has been omitted for
clarity. (f) Same slice through representation like in (e) but for FolT2.
DOI: https://doi.org/10.7554/eLife.35828.009
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Second, PduO is a Cbl adenosyltransferase, which converts Cbl into Ado-Cbl making it accessible
for NrdJ. We showed that ECF-CbrT not only transports Cbl, but also mediates uptake of Cbi
(Figure 3a). Therefore L. delbrueckii is expected to have the genetic repertoire to synthesize Cbl
using Cbi as a precursor. However, we could not find homologs of the enzymes CobS, CobU and
CobT, which are known to convert Cbi into cobalamin in E. coli (Lawrence and Roth, 1995). Possibly
other proteins might functionally compensate for their absence, which was shown for the thiamin
kinase YcfN, which could replace CobU in Salmonella typhimurium (Otte et al., 2007). However, it is
also possible that L. delbrueckii CbrT binds Cbi in a futile mannerin which case Cbi would be trans-
ported but not used as a substrate for any enzyme. Finally, predicted CbrT homologs in Lactobacil-
lales display a high degree of sequence identity, ranging from 25% to 60% compared to L.
delbrueckii CbrT. Thus, we hypothesize that these CbrT homologs share the same function and rep-
resent substrate binding proteins for both Cbl and Cbi.
Our results show that ECF-CbrT is a new vitamin B12 transporter that is able to restore Cbl- and
Cbi-dependent growth in E. coli DFEC (Figure 2c). Further characterization using uptake experi-
ments with the purified ECF-CbrT complex (Figure 3a) and binding studies on CbrT show that the
transporter is promiscuous towards the b-ligand of Cbl and also accepts Cbi as substrate
(Figure 3b). A similar behavior has also been observed for BtuCDF (Mireku et al., 2017).
All three naturally occurring Cbl variants, OH-Cbl, Ado-Cbl and Met-Cbl, inhibit uptake of radiola-
beled cyano-Cbl (Figure 3b). Whereas almost full inhibition was observed by a 250-fold excess of
OH-Cbl, CN-Cbl, and Met-Cbl, Ado-Cbl inhibited only to 25%. This might be due to its bulkier b-
ligand and a consequent steric hindrance. Nonetheless, the assay shows that ECF-CbrT is promiscu-
ous toward the b-axial ligand of vitamin B12. Generally, poly-specificity to Cbl (and Cbl-derivatives,
see below) and Cbi seems to be an inherent feature of vitamin B12 binding proteins, which is the
case for BtuF, human Cbl-carriers, and also CbrT (Fedosov et al., 1995; Mireku et al., 2017). In the
human Cbl-carriers that share a similar promiscuity, the b-ligand side of the bound substrate is par-
tially solvent exposed (Furger et al., 2013; Mathews et al., 2007; Wuerges et al., 2007). In CbrT,
the broader substrate specificity might be related to flexibility of loops 1 and 3 that are the gates of
CbrT and would make contact with the varying b-axial ligands.
In other ECF-transporters, the S-components exhibit remarkable high affinities toward their
respective substrates with Kd values in the low nanomolar range (Slotboom, 2014). ITC measure-
ments with CbrT in the absence of the ECF module also show high-affinity binding of CN-Cbl, OH-
Cbl, Met-Cbl, and Cbi (Figure 4b,c and e). The slightly lower affinity for Cbi (4-fold) is probably due
to the lack of the a-igand (Figure 1—figure supplement 1) that leads to fewer possible protein-sub-
strate interactions.
Strikingly, the affinity binding constants for CN-Cbl and Cbi are in the same range as the respec-
tive affinities determined for BtuF (Cbl of 9.1 nM and Cbi of 40 nM) (Mireku et al., 2017), which
might imply that Cbl-transporters evolved to acquire the substrates with similar efficiency. Together
with our Vmax and KM (Figure 3—figure supplement 1) determination, we additionally show that the
rate limiting step is substrate translocation, which means that the observed affinities are probably
optimized for efficient substrate scavenging, followed by a slow translocation step. Human carriers
achieve even higher affinities for Cbl (in the sub-picomolar range) (Fedosov et al., 1995), but in
these cases, the off rate is practically zero and substrate release requires proteolysis, which is not
the mechanism of (ABC-) transporters.
Although it was already known for a long time that a plethora of uncharacterized prokaryotic vita-
min B12 uptake systems must exist, only the BtuCDF complex had been extensively characterized.
This is somewhat surprising, considering the potential relevance of bacterial vitamin B12 transport
for pharmaceutical applications. For instance, given the increase in antibiotic resistance and its seri-
ous threat to public health (Alo´s, 2015), it is imperative to find and characterize novel protein tar-
gets for drug design. Several pathogenic bacteria, such as Streptoccoccus pyogenes and
Clostridium tetani, carry a cbrT gene, lack a BtuCDF homolog, and are Cbl-auxotrophs, which makes
them strictly dependent on dedicated transporters to scavenge either vitamin B12 or its precursors
from the environment. Because humans use endocytosis to take up Cbl (Quadros, 2010), Cbl-spe-
cific prokaryotic transporters are potential drug targets for vitamin B12 auxotrophic pathogens.
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Crystal structure of ECF-CbrT
Molecular methods
For expression, CbrT (LDB_RS00385) was amplified by means of polymerase chain reaction (PCR)
using L. delbrueckii subsp. bulgaricus genomic DNA as a template. For expression of the entire com-
plex, CbrT was inserted into the second multiple cloning site of p2BAD_ECF (Swier et al., 2016)
with XbaI and XhoI restriction sites. For expression of solitary CbrT, the gene was inserted with a
C-terminal octa-His-tag into pBAD24 (Guzman et al., 1995) using NcoI and HindIII restriction sites.
A single glycine (Gly2) was introduced to be in-frame with the start-codon of the NcoI restriction
site, which is not present in the full complex. All primers used are listed in Supplementary file 2 and
all sequences were checked for correctness by sequencing.
Expression and membrane vesicle preparation
ECF–CbrT was expressed as described previously (Swier et al., 2016) with the following adapta-
tions; plain Luria Miller broth (LB) medium was used and the growth temperature was kept constant
at 37˚C throughout. After 3 hr of expression, the cells were harvested by centrifugation (20 min,
7,446  g, 4˚C) and resuspended in 50 mM KPi, pH 7.5. Cells were either immediately used for
membrane vesicles preparation or the resuspended cells were flash frozen in liquid nitrogen and
stored at  80˚C until use. Membrane vesicles were prepared as previously described (Swier et al.,
2016)
ECF-CbrT purification
Crude membrane vesicles containing ECF-CbrT were solubilized in buffer A (50 mM KPi, pH 7.5, 300
mM NaCl, 10% glycerol, 1% (w/v) n-dodecyl-b-D-maltopyranoside (DDM, Anatrace) for 45 min at
4˚C under constant movement. Unsolubilized material was removed by centrifugation (35 min,
287,000  g, 4˚C), the supernatant was loaded on a BioRad PolyPrep column containing 0.5 mL
Ni2+-sepharose bed volume (GE healthcare), pre-equilibrated with 20 column volumes (CV) buffer B
(50 mM KPi, pH 7.5, 300 mM NaCl, 10% glycerol) and allowed to incubate for 1 hr at 4˚C under con-
stant movement. Unbound protein was allowed to flow through and the column was washed with 20
CV of buffer C (50 mM KPi, pH 7.5, 300 mM NaCl, 10% glycerol, 50 mM imidazole, 0.05% DDM).
ECF–CbrT was eluted with buffer D (50 mM KPi, pH 7.5, 300 mM NaCl, 10% glycerol, 500 mM imid-
azole, 0.05% (w/v) DDM) in three fractions of 0.4 ml, 0.75 ml and 0.5 ml, respectively. ECF-CbrT
eluted mostly in the second elution fraction that was loaded on a Superdex 200 Increase 10/300 gel
filtration column (GE Healthcare) that was equilibrated with buffer E (50 mM Hepes pH 8, 150 mM
NaCl, 0.05% DDM). For crystallization, ECF-CbrT was purified following the same protocol but buf-
fers A to D contained 1% DDM. Buffers A to D were supplemented with 0.5 mM hydroxyl-cobalamin
(OH-Cbl, Sigma Aldrich), and buffer E contained 10 mM OH-Cbl. For all experiments, the peak frac-
tions were collected, combined and either used directly for reconstitution or concentrated in a Viva-
spin disposable ultrafiltration device with a molecular weight cut-off of 30 kDa (Sartorius Stedim
Biotech SA) to a final concentration of 6 mg*ml 1.
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Construction of the E. coli DFEC strain
The E. coli strains JW0154 (DbtuF::KmR), JW3805(DmetE::KmR) and JW1701(DbtuC::KmR) from the
Keio collection (Baba et al., 2006) were purchased from the Coli Genetic Stock Center, Yale. E. coli
JW0154 (DbtuF::KmR) was used as the basis for constructing E. coliDFEC. The kanamycin resistance
cassette of JW0154 was removed using the FLP recombinase as described before (Datsenko and
Wanner, 2000), resulting in E. coliDF. The metE::KmR locus from JW3805 was introduced in E. coliDF
using P1-mediated generalized transduction as described (Miller, 1972; Thomason et al., 2007),
resulting in E. coliDFE::KmR. The kanamycin cassette was removed using the FLP recombinase,
resulting in E. coliDFE. The DbtuC::KmR locus of JW1701 was introduced in E. coliDFE using P1-medi-
ated generalized transduction, resulting in E. coliDFEC. Colony PCRs based on three primer pairs
(buF-locus, 5’-atggctaagtcactgttcagg-3’ and 5’-ctaatctacctgtgaaagcgc-3’; butC-locus, 5’-atgctga-
cacttgcccgc-3’ and 5’-ctaacgtcctgcttttaacaataacc-3’; metE-locus, 5’-atgacaatattgaatcacaccctcg-3’
and 5’-ttacccccgacgcaagttc-3’) were used to verify KmR-insertions, the FLP-recombinase-mediated
removal of KmR-markers and the absence of any genomic duplications resulting in the presence of
any wild-type metE, btuC and btuF loci.
Growth assay with E. coli DFEC strains
The strains carrying various expression vectors were grown overnight at 37˚C on LB-agar plates sup-
plemented with 25 mg*ml 1 kanamycin and 100 mg*ml 1 ampicillin. The composition of the M9-
based (47.7 mM Na2HPO4*12H2O, 17.2 mM KH2PO4, 18.7 mM NH4Cl, 8.6 mM NaCl) minimal
medium was supplemented with 0.4% glycerol, 2 mM MgSO4, 0.1 mM CaCl2, 100 mg*ml
 1L-argi-
nine, 25 mg*ml 1 kanamycin and 100 mg*ml 1 ampicillin. A single colony was picked and used to
inoculate a 3 ml to 6 ml liquid pre-culture supplemented with 50 mg*ml 1L-methionine (Sigma-
Aldrich). The pre-culture was grown ~ 24 hr at 37˚C, shaking in tubes with gas-permeable lids (Cell-
star). The main cultures were inoculated in a 1:500 inoculation ratio. The main culture had a volume
of 200 ml and was supplemented with 0.00001% L-arabinose (Sigma-Aldrich) and either 50
mg*ml 1 L-methionine, 1 nM dicyano-cobinamide (Sigma Aldrich), or 1 nM cyano-cobalamin (Acros
Organics). The medium was added to a sterile 96 well-plate (Cellstar). The 96-well plate was sealed
with a sterile and gas-permeable foil (BreatheEasy, Diversified Biotech). The cultures were grown for
1000 min in a BioTek Power Wave 340 plate reader at 37˚C, shaking. The OD600 was measured every
five minutes at 600 nm. All experiments were conducted as technical triplicates from biological tripli-
cate. To obtain lag-times the averaged growth curves were fitted with the Gompertz-fit in Origin
eight and further analyzed as described (Zwietering et al., 1990).
Crystallization and structure determination
Initial crystallization conditions for ECF-CbrT were screened at 4˚C using commercial sparse-matrix
crystallization screens in a sitting-drop setup and a Mosquito robot (TTP Labtech, UK). Initial crystals
were found in the B11 condition (0.2 M KCl, 0.1 M Sodium citrate, pH 5.5, 37% (v/v) Pentaerythritol
propoxylate (5/4 PO/OH)) of the MemGold1 HT-96 screen (Molecular Dimensions, UK) that dif-
fracted up to 7.5 A˚ resolution. Using this condition as a starting point and the detergent (HR2-408)
screen (Hampton Research, USA), an optimized condition could be found and contained the deter-
gent ANAPOEÒ-C12E10 (Polyoxyethylene(10)dodecyl ether, Hampton Research) as an additive, which
yielded crystals diffracting up to 3.4 A˚ resolution.
X-ray diffraction data were collected from cooled (100 K) single crystals at synchrotron beam lines
at the Swiss Light Source (SLS) beamline PXI, Switzerland. The crystals of apo ECF–CbrT belong to
space group P1 (unit cell parameters: a = 85.47, b = 92.86, c = 105.51, a = 72.568, b = 66.274,
g = 62.893).
To correct for anisotropy, the dataset was treated at the diffraction anisotropy server prior to fur-
ther processing (Strong et al., 2006). Data were processed with XDS (Kabsch, 2010b) and scaled
with Xscale (Kabsch, 2010a). Data collection statistics are summarized in Supplementary file 1. The
structure of the ECF-CbrT complex was solved by molecular replacement with PHASER MR
(McCoy et al., 2007) using the apo ECF-FolT structure of L. delbrueckii (Swier et al., 2016) (PDB
code 5JSZ) as a search model. For model completion, several cycles of model building with COOT
(Emsley et al., 2010) and refinement with PHENIX (Adams et al., 2010) were performed. The Rama-
chandran statistics are 72.32% for favoured regions, 26.64% for allowed regions and 1.05% for
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outliers. All structural figures in the main text were prepared with an open-source version of pymol
(https://sourceforge.net/projects/pymol/).
Preparation of radiolabeled cobinamide from radiolabeled cobalamin
The required amount of cyano-cobalamin (radiolabeled and unlabeled) was mixed in a 1:1 (v/v) ratio
with 70% perchloric acid (Sigma-Aldrich) and incubated for ten minutes at 70˚C. To quench the reac-
tion and prevent damage to the substrate, the resulting cobinamide substrate was added to buffer
G (as described above), which was additionally supplemented with 5 M NaOH to restore the pH
back to 7.5.
Radiolabeled vitamin B12 transport assay
Purified ECF-CbrT was reconstituted in proteoliposomes as described previously (Geertsma et al.,
2008). Proteoliposomes were thawed and loaded with 5 mM MgSO4 or MgCl2 and 5 mM Na2-ATP
or Na2-ADP through three freeze-thaw cycles. Loaded proteoliposomes were extruded nine times
through a polycarbonate filter with a 400 nm pore-size (Avestin), pelleted by centrifugation (267,008
g, 35 min, 4˚C) and resuspended in buffer F (50 mM KPi pH 7.5) to 2 ml*mg 1 lipids. The uptake
reaction was started by addition of concentrated and loaded proteoliposomes to buffer G (50 mM
KPi pH 7.5, varying concentrations of 57Co-cyanocobalamin (150 to 300 mCi*mg 1, in 0.9% benzylal-
cohol, MP Biomedicals) in a 1:100 ratio. At elsewhere specified time points 200 ml samples were
taken transferred into 2 ml ice cold buffer F and filtered over OE67 cellulose acetate filters (GE
Healthcare) soaked in Buffer F supplemented with cyanocobalamin (Acros chemicals). The filter was
washed with 2 ml ice cold buffer F and transport of radiolabeled substrate was counted in Perkin
Elmer Packard Cobra II gamma counter. All uptake assays were performed at 30˚C while stirring.
Substrate-binding assay by isothermal thermal calorimetry (ITC)
ITC measurements were performed using a NanoITC calorimeter (TA Instruments) at 25˚C. Mem-
brane vesicles containing CbrT (200 ml, 10 mg*ml 1 in 50 mM KPi, pH 7.5) were added to the Nano-
ITC cell. Ligands were prepared in 50 mM KPi, pH 7.5 and titrated into the cell in 1 ml injections with
140 s between each injection. Membrane vesicles containing the full-complex ECF-CbrT that does
not bind CN-Cbl (10 mg*ml 1 in 50 mM Kpi, pH 7.5) were used as a negative control. Data were
analyzed with the Nano Analyze Software.
Data deposition
The atomic coordinates and structure factors have been deposited in the Protein Data Bank, www.
pdb.org (PDB ID code 6FNP).
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